🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
30 Servings
Fat/Fatty Acid Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

Calories
25 Calorie(s)
Total Fat
2.5 Gram(s) (3% DV)
Cholesterol
5 mg (2% DV)
Protein
1 Gram(s)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1400mg UL 3000mg

Other Ingredients

Re-Esterified Triglyceride Fish Oil Fish Oil Gelatin Glycerine Water, Purified Lemon Flavor, Natural natural Tocopherols Rosemary Extract Ascorbyl Palmitate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested usage: As a dietary supplement, adults take two (2) softgels daily with a meal or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

Tamper resistant - do not use if imprinted safety seal under cap is broken or missing.

🧪 Formulation Notes

Gluten free, Non-GMO

This fish oil is the superior re-esterified Triglyceride (rTG) form for optimal absorption.

Oil from wild ocean caught anchovy is molecularly distilled to remove contaminants.

For optimal health

1,400 mg Omega-3 720 mg EPA & 480 mg DHA

Additional Information

For optimal storage conditions, store in a cool, dry place. (59 degrees -77 degrees F/15 degrees -25 degrees C) (35-65% relative humidity)

Physician formulated Cooper aerobics health & wellness

Product Details

UPC / SKU 8 16899 00009 6
DSLD Entry Date 2023-12-14
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 303452
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →